Understanding how a specific protein affects immune cells in type 1 diabetes

Mechanisms by which PIM kinase modulates the effector function of autoreactive CD8 T cells in type 1 diabetes

NIH-funded research Medical College of Wisconsin · NIH-11060012

This study is looking at how a protein called PIM1 affects immune cells that mistakenly attack the insulin-producing cells in people with type 1 diabetes, with the hope of finding new ways to help manage or treat the condition.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin NIH-funded
Lab location1 site (Milwaukee, United States)
Project IDNIH-11060012 on NIH RePORTER

What this research studies

This research investigates the role of PIM1, a protein kinase, in regulating the function of immune cells that attack insulin-producing cells in type 1 diabetes. By studying how PIM1 influences the behavior of autoreactive CD8 T cells, the research aims to uncover new therapeutic targets that could help manage or treat this autoimmune condition. The approach includes advanced techniques like single-cell RNA sequencing to analyze the molecular mechanisms at play. If successful, this research could lead to innovative treatments that improve the lives of those affected by type 1 diabetes.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes who are experiencing challenges with insulin management.

Not a fit: Patients with type 2 diabetes or other non-autoimmune related diabetes conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide new therapeutic strategies to better manage or potentially reverse type 1 diabetes.

How similar studies have performed: Other research has shown promise in targeting immune cell functions in autoimmune diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Milwaukee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune DiabetesAutoimmune Diseasesautoimmune disorderautoimmunity disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.